The UO Institutional Biosafety Committee (IBC) was established by the authority of the university president. The committee was created as a requirement under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guildelines). All work involving recombinant or synthetic nucleic acid molecules must be registered with the IBC.   Description of additional types of experiments that must be registered with the IBC are detailed in the committee's Bylaws & Operating Procedures.

UO IBC 2024 meetings are held remotely on the first Friday of the month for the 2025-2026 academic year.

The next meeting date for the 2026-2027 academic year will be October 2026.

Summary Guide to the NIH Guidelines and PI Responsibilities.

Contacts

• Laurie Graham, Laboratory Safety Manager, Biosafety Officer (P) 541-346-2864

Training Review

• NIH Guidelines: Overview
• NIH Guidelines: Safety Considerations
• NIH Guidelines: IBC and Levels of Review
• NIH Guidelines: Responsibilities-Institutional and PI
• NIH Guidelines: Risk Assessment

Process

Form new for 2026

Meeting Minutes 2025-2026 academic year

November 2025, December 2025, March 2026, April 2026, May 2026,June 2026,